Carley Heck

Carley Heck is a Principal Scientist at Pfizer, specializing as the Oncology Lead in Small Molecule Biotransformation since August 2019. Previously, Carley served as a Senior Scientist, focusing on biotransformation and structural elucidation. Carley's academic background includes a PhD in Pharmacology and Molecular Sciences from Johns Hopkins University, where work involved investigating the relationship between cytochrome P450 drug metabolism and hepatotoxicity of HIV medications. Carley has also gained research experience through internships at Amgen and USAMRIID, as well as undergraduate research at Shippensburg University, showcasing a strong foundation in drug metabolism, assay development, and data analysis throughout various projects.